| Поле DC | Значение | Язык |
|---|
| dc.contributor.author | Khokhlov, A. L. | - |
| dc.contributor.author | Yaichkov, I. I. | - |
| dc.contributor.author | Korsakov, M. K. | - |
| dc.contributor.author | Shetnev, A. A. | - |
| dc.contributor.author | Ivanovskiy, S. A. | - |
| dc.date.accessioned | 2024-05-02T08:46:51Z | - |
| dc.date.available | 2024-05-02T08:46:51Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.citation | Identification and synthesis of metabolites of the new antiglaucoma drug / A.L. Khokhlov, I.I. Yaichkov, M.K. Korsakov [et al.] // Research Results in Pharmacology. - 2024. - Vol.10, №1.-P. 53-66. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/62664 | - |
| dc.description.abstract | The determination of biotransformation products is an essential part of the preclinical trial of original medicines. These studies have not been conducted before for the new drug 5-[5- (trifluoromethyl)-1,2-oxazole-3-yl]-furan-2-sulfonamide. Identification and synthesis of metabolite substances are necessary for subsequent tests of bioavailability, linearity of pharmacokinetics, accumulation, distribution and excretion | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | biotransformation | ru |
| dc.subject | selective carbonic anhydrase II inhibitor | ru |
| dc.subject | HPLC-MS/MS | ru |
| dc.subject | N-hydroxysulfonamide | ru |
| dc.subject | Nacetylsulfonamide | ru |
| dc.subject | isoxazole | ru |
| dc.subject | sulfonamide | ru |
| dc.title | Identification and synthesis of metabolites of the new antiglaucoma drug | ru |
| dc.type | Article | ru |
| Располагается в коллекциях: | Vol. 10, № 1
|
